What is Pine Biotech?
Pine Biotech, established in 2014, is dedicated to democratizing biomedical data analysis. Originating from experts at the Tauber Bioinformatics Research Center, University of Haifa, the company developed the T-BioInfo platform. This multi-omics platform is designed for user-friendliness, integrating large, disparate datasets and employing AI technology to simplify complex analyses for users with limited bioinformatics experience. The platform supports both conventional and custom machine learning methods. Complementing its software, Pine Biotech offers a comprehensive suite of educational courses, workshops, and diploma programs through university partnerships, enabling students globally to learn bioinformatics via hands-on experience with the T-BioInfo platform and the OmicsLogic curriculum. The company operates from the New Orleans Bioinnovation Center and maintains extensive collaborations with research institutions worldwide.
How much funding has Pine Biotech raised?
Pine Biotech has raised a total of $1M across 1 funding round:
Unspecified
$1M
Unspecified (2017): $1M, investors not publicly disclosed
What's next for Pine Biotech?
With a substantial enterprise-level funding context and a recent major strategic investment, Pine Biotech is well-positioned for accelerated growth and market expansion. The company's focus on integrating advanced bioinformatics tools with accessible educational content suggests a strategy aimed at broadening the user base for complex biological data analysis. Future initiatives are likely to involve further development of the T-BioInfo platform, enhancement of its AI capabilities, and expansion of its educational offerings to meet the growing demand for skilled bioinformaticians. This strategic financing will likely fuel research and development, bolster marketing efforts, and strengthen collaborations with academic and industry partners, solidifying Pine Biotech's role as a key enabler of scientific discovery.
See full Pine Biotech company page
